Evidence map›Paper›PMID 38153810›Full record

ArticleJAMA health forum2023

Biosimilar Uptake in Medicare Advantage vs Traditional Medicare.

Steven Kozlowski, Andrew Kwist, Rowan McEvoy, Nirabh Koirala, Yoganand Chillarige, Jeffrey A Kelman, David J Graham

Abstract read
In one paragraph

Article in JAMA health forum, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Steven KozlowskiCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
Andrew KwistAcumen LLC, Burlingame, California.
Rowan McEvoyAcumen LLC, Burlingame, California.
Nirabh KoiralaAcumen LLC, Burlingame, California.
Yoganand ChillarigeAcumen LLC, Burlingame, California.
Jeffrey A KelmanCenters for Medicare & Medicaid Services, Washington, DC.
David J GrahamCenter for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biosimilar PharmaceuticalsMedicare Part CBiological TransportUnited StatesBiosimilar Pharmaceuticals

Identifiers

PMID38153810
PMCPMC10755621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.